Dental Membrane And Bone Graft Substitutes Market (2025 - 2033)

Dental Membrane And Bone Graft Substitutes Market Summary

The global dental membrane and bone graft substitutes market size was valued at USD 1.47 billion in 2024 and is projected to reach USD 2.96 billion by 2033, growing at a CAGR of 8.19% from 2025 to 2033. The demand for dental membranes and bone graft substitutes is rising owing to the increasing burden of dental disorders and the growing demand for aesthetic and restorative dental procedures.

In addition, increasing dental tourism is also expected to propel market growth. The rising global prevalence of dental disorders, including periodontal disease, tooth decay, tooth loss, and oral cancer, significantly drives demand in the dental membrane and bone graft substitutes market. According to World Health Organization data published in March 2025, more than 1 billion people suffer from severe periodontal disease worldwide. Additionally, about 7% of adults aged 20 and above and around 23% of those over 60 experience complete tooth loss, often requiring implants and bone regeneration procedures. These statistics underscore the growing necessity for dental implants and bone regeneration procedures, as tooth loss frequently leads to jawbone deterioration, requiring bone graft substitutes and membranes to support successful implant integration.

Moreover, the increasing incidence of oral cancer is anticipated to boost the demand for dental bone grafts further. During surgical treatment for oral cancer, bone grafts are frequently required to reconstruct and restore areas of the jawbone that have been damaged or removed during tumor excision. This underscores the vital role that bone graft substitutes play in facilitating successful surgical outcomes and post-operative rehabilitation.

Table 1 Projected number of lip, oral cavity cancer cases by country in North America, 2025 and 2030

Source: IARC

Furthermore, the rising demand for restorative and aesthetic dental procedures like dental implantation is anticipated to significantly drive the growth of the dental membrane and bone graft substitutes market. When bone is insufficient to support an implant securely, bone grafting becomes essential. In addition, a dental membrane protects the graft site and prevents gum tissue from disrupting bone regeneration, thereby enhancing healing and improving graft success rates. As the preference for procedures like dental implantation continues to grow, so does the demand for supportive materials such as dental membranes and bone graft substitutes. According to a study published by Twin Dental New York in June 2025, about 5 million new dental implants are placed yearly in the U.S. alone. Thus, the significant population undergoing dental implantation is anticipated to drive the demand for dental membranes and bone graft substitutes.

Key Opinion Leaders

Source: Grand View Research Analysis

Market Concentration & Characteristics

The market growth stage is high, and the pace of growth is accelerating. The dental membrane and bone graft substitutes market is characterized by high growth owing to the rising demand for aesthetic and restorative dentistry, growing launches of novel products, and increasing burden of dental disorders.

The increasing number of clinical trials focused on dental membranes and bone graft substitutes reflects the market's growing emphasis on innovation and biocompatibility. Manufacturers are actively investing in developing advanced materials, including resorbable membranes entirely free from animal-derived components. For instance, in August 2025 VIVOLTA and Fibrothelium partnered to produce SimplySilk-an advanced, CE-marked resorbable membrane engineered using proprietary silk fibroin technology. Specifically designed for guided bone regeneration (GBR) in dental surgeries, SimplySilk features a unique multi-layered, electrospun structure that provides extended barrier function and supports predictable tissue healing. This innovation underscores the industry's shift toward synthetic, high-performance solutions that align with both clinician and patient demands for safety, efficacy, and ethical sourcing.

Regulatory bodies such as the U.S. FDA, Health Canada, and the European Medicines Agency (EMA) oversee the approval, classification, and monitoring of dental membranes and bone graft substitutes. These products are regulated based on their materials and associated risk. For example, the FDA classifies standard bone grafts and membranes as Class II devices, requiring special controls, while those containing biologics like bone morphogenetic proteins (BMPs) fall under Class III and require premarket approval as combination products. Regulatory non-compliance, such as unauthorized product distribution or lack of approval, can lead to significant penalties, product recalls, and market bans, as occurred in enforcement actions by authorities like the FDA and the TGA in Australia.

Mergers and acquisitions are key strategic approaches in the dental membrane and bone graft substitutes industry. They allow companies to broaden their product portfolios, drive innovation, and enhance their market position. For instance, in November 2024, RTI Surgical announced that it had concluded the acquisition of Collagen Solutions, a global supplier of engineered medical-grade xenograft and collagen tissue.

Dental membrane and bone graft substitutes companies are increasingly focusing on regional expansion to enhance market access and meet the growing demand for advanced dental solutions. A key part of this strategy involves securing marketing authorizations from various regulatory bodies. For instance, in September 2024, Regenity Biosciences, a global player in regenerative medicine and a Linden Capital Partners portfolio company, received regulatory approval from China’s NMPA for its novel Matrixflex resorbable membrane. This crosslinked, bioresorbable collagen membrane is designed for use in oral surgical procedures.

Product Insights

The bone graft substitutes (BGS) segment held the largest share of the dental membrane and bone graft substitutes market in 2024. It is also anticipated to grow fastest with a CAGR of 8.92% from 2025 to 2033. The increasing development and launch of synthetic bone graft products drive this robust growth. For example, in February 2023, Nobel Biocare introduced creos syntogain-a biocompatible, synthetic bone substitute featuring a multidirectional interconnected porous structure designed for applications in oral, periodontal, and maxillofacial surgeries. The continued introduction of such advanced, biocompatible synthetic grafts is expected to significantly contribute to the segment’s expansion in the years ahead.

The dental membranes and soft tissue regeneration materials segment is expected to witness substantial growth during the forecast period, primarily driven by a rise in regulatory approvals for resorbable membranes. For instance, in May 2023, Biomatlante announced that its EZ Cure Resorbable Collagen Membrane received Medical Device Regulation (MDR) approval in Europe, signaling increased market readiness and clinical acceptance of advanced regenerative solutions.

Application Insights

The socket preservation segment led the market with a total revenue share of 27.61% in 2024. This growth is primarily driven by the increasing prevalence of dental disorders and the rising volume of dental procedures, including implant placements and tooth extractions. For instance, the Oral Health Foundation reported in February 2024 a significant 17% rise in decay-related tooth extractions among individuals aged 0 to 19 in NHS hospitals during the 2022-2023 financial year compared to 2021-2022. The growing number of dental procedures is expected to drive the segment growth.

The sinus lift segment is expected to register the fastest growth rate in the dental membrane and bone graft substitutes market over the forecast period. This growth is primarily fueled by the anatomical challenges of the upper posterior jaw, where limited bone height and proximity to the sinus cavity make implant placement difficult. Sinus lift procedures help create sufficient vertical bone volume, enhancing implant stability and success rates. Additionally, rising adoption of dental implants, increasing prevalence of edentulism among the aging population, and the growing demand for permanent tooth replacement are further driving the demand for sinus lift procedures.

Regional Insights

In 2024, North America held the largest revenue share of 37.90% in the dental membrane and bone graft substitutes market. The regional market is driven by an aging population increasingly affected by edentulism, periodontitis, and peri-implant bone loss. The rapid expansion of implant dentistry and rising patient expectations for functional and aesthetic results further support growth. Additionally, advancements in biomaterials-such as next-generation collagen and synthetic membranes-enhance tissue regeneration outcomes while minimizing surgical morbidity, contributing significantly to higher adoption among clinicians and patients alike.

U.S. Dental Membrane And Bone Graft Substitutes Market Trends

The U.S. dental membrane and bone graft substitutes market is expected to grow significantly, driven by the increasing number of maxillofacial surgeries and a rising incidence of trauma-related dental injuries, often resulting from road accidents. According to the data published by the National Safety Council, in 2023, motor vehicle crashes in the U.S. led to 44,762 fatalities and approximately 5.1 million medically consulted injuries, underscoring the substantial health and economic impact, fueling demand for reconstructive dental procedures.

Europe Dental Membrane And Bone Graft Substitutes Market Trends

The European dental membrane and bone graft substitutes market is growing due to an aging population and increased bone-related disorders like osteoporosis and tooth loss, boosting demand for implants and grafting procedures. Advances in implantology and biomaterials, including synthetic grafts and growth factors like BMP-2, have enhanced bone regeneration and patient outcomes. Additionally, the rising preference for synthetic grafts-driven by ethical concerns, affordability, and safety-is improving European accessibility.

The UK dental membrane and bone graft substitutes market for dental membranes and bone graft substitutes is experiencing growth, mainly driven by increasing demand for dental implants and regenerative dentistry. An aging population, combined with a high prevalence of tooth loss from periodontal disease, caries, and extractions, is fueling the need for bone regeneration procedures to support successful implant placement. According to data from the Royal College of Surgeons of England (February 2025), there were 30,587 hospital episodes of tooth extractions among children and young people aged 0 to 19, primarily due to tooth decay.

The France dental membrane and bone graft substitutes market is poised for rapid growth in the coming years. France’s rapidly aging population is a key driver of market growth. According to the French National Institute for Statistics and Economic Studies (INSEE), as of January 1, 2024, over one in five residents (21.5%), or 14.7 million people, were 65 and older. This aging population drives increased rates of tooth loss, periodontal disease, and bone resorption, boosting demand for dental implants and regenerative materials like bone graft substitutes and membranes, fueling market growth in France.

Asia Pacific Dental Membrane And Bone Graft Substitutes Market Trends

The Asia Pacific dental membrane and bone graft substitutes market is growing fastest, driven by rising oral disease prevalence, an aging population, and increased dental awareness. Technological advancements, government health initiatives, and medical tourism further boost demand. Dentists play a key role by adopting advanced regenerative therapies and educating patients, especially in countries like China, India, Japan, and Australia, fueling market expansion.

The India dental membrane and bone graft substitutes market is anticipated to witness lucrative growth. Dentists are driving growth in India’s dental membrane and bone graft substitutes market through increased use of advanced biomaterials like resorbable membranes and synthetic grafts. Rising patient awareness, a growing prevalence of oral disorders, and an aging population are boosting demand. According to data published by The Hindu in March 2025, nearly 60 % of India's population is affected by dental caries, and approximately 85% suffer from gum disease.

The China dental membrane and bone graft substitutes market is anticipated to witness a lucrative growth. Rising oral cancer cases and an aging population drive the country market. Increased surgeries for cancer and age-related tooth loss boost demand for reconstructive materials. Advances in biomaterials and growing patient awareness support market growth amid the rising prevalence of oral disease.

Latin America Dental Membrane And Bone Graft Substitutes Market Trends

The Latin America dental membrane and bone graft substitutes market is experiencing steady growth. Brazil and Argentina are driving growth in Latin America market through rising implant procedures and improved access to private dentistry. Dentists play a key role by adopting advanced regenerative treatments and resorbable materials, supported by training, regulatory approvals, and digital technologies, which enhance patient acceptance and expand treatment options across the region.

Middle East & Africa Dental Membrane And Bone Graft Substitutes Market Trends

The Middle East and Africa dental membranes and bone graft substitutes market is growing due to high dental disease prevalence, an aging population, and advances in biomaterials. Rising dental tourism in countries like the UAE and Turkey, increased healthcare spending, and expanding private practices drive demand.

The Saudi Arabia dental membrane and bone graft substitutes market is set for robust growth, fueled by increased investments in public and private healthcare and expanding healthcare infrastructure. The country’s Vision 2030 initiative supports this growth by enhancing access to preventive and restorative dental care, integrating dental services, and raising public awareness. Additionally, the aging population drives demand for advanced regenerative treatments and dental implants, further propelling market expansion.

Key Dental Membrane And Bone Graft Substitutes Company Insights

Dentsply Sirona, Bioteck S.p.A., Maxigen Biotech Inc., Institut Straumann AG, Nobel Biocare Services AG (Envista), Geistlich Holding, ZimVie Inc., NovaBone (Halma), Osteogenics Biomedical (Envista), Regenity, Medtronic, BioHorizons, REGEDENT AG, IDL Dental Technologies LTD, EUCARE PHARMACEUTICALS (P) LTD, Curasan, Inc., TBR Dental, DentiumUSA, Tecnoss Dental Srl (Tecnoss s.r.l.), Unicare Biomedical, Inc., Neoss, Advanced Medical Solutions Group plc, B&B Dental Implant Company, botiss, Septodont Holding, Implant Direct Corporation (Envista), META BIOMED CO,. LTD, and SigmaGraft Biomaterials are some of the major players in the dental membrane and bone graft substitutes market. Companies are broadening their range of dental membranes and bone graft substitutes and are placing greater emphasis on obtaining regulatory approvals to satisfy increasing demand. Additionally, industry players are collaborating to enhance their competitive edge.

Recent Developments

• In February 2025, LifeNet Health introduced OraGen, the first viable dental bone allograft made from cryopreserved corticocancellous bone that contains demineralized bone matrix and endogenous lineage-committed bone cells.

• In November 2024, RTI Surgical announced that it had concluded the acquisition of Collagen Solutions, a global supplier of engineered medical-grade xenograft and collagen tissue.

• In September 2024, Regenity Biosciences, a global player in regenerative medicine and a Linden Capital Partners portfolio company, received regulatory approval from China’s NMPA for its novel Matrixflex resorbable membrane. This crosslinked, bioresorbable collagen membrane is designed for use in oral surgical procedures.

Dental Membrane And Bone Graft Substitutes Market